Explore
Validate
Learn
Western blot
ImmunohistochemistryAntibody data
- Antibody Data
- Antigen structure
- References [10]
- Comments [0]
- Validations
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 25175-1-AP - Provider product page
- Provider
- Proteintech Group
- Product name
- Glypican 3 antibody
- Antibody type
- Polyclonal
- Description
- Glypican 3 antibody (Cat. #25175-1-AP) is a rabbit polyclonal antibody that shows reactivity with human and has been validated for the following applications: WB,ELISA.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Bioinformatics analysis identifies heparan sulfate proteoglycans acting as different progress subtypes of biliary atresia.
The effect of hormones insulin and glucagon on ubiquitin modifications elucidated by proteomics in liver cells.
HMGB1/GPC3 dual targeting vaccine induces dendritic cells-mediated CD8(+)T cell immune response and elicits potential therapeutic effect in hepatocellular carcinoma.
Enhanced glypican-3-targeted identification of hepatocellular carcinoma with liver fibrosis by pre-degrading excess fibrotic collagen.
Therapeutic Adenovirus Vaccine Combined Immunization with IL-12 Induces Potent CD8(+) T Cell Anti-Tumor Immunity in Hepatocellular Carcinoma.
A Case of Early-Stage Gallbladder Cancer, Positive for ALDH1A1, Which Arose from Adenomyomatosis of the Gallbladder.
TCF11 Has a Potent Tumor-Repressing Effect Than Its Prototypic Nrf1α by Definition of Both Similar Yet Different Regulatory Profiles, With a Striking Disparity From Nrf2.
The Mutational Features of Aristolochic Acid-Induced Mouse and Human Liver Cancers.
hPCL3s Promotes Hepatocellular Carcinoma Metastasis by Activating β-Catenin Signaling.
Butaselen prevents hepatocarcinogenesis and progression through inhibiting thioredoxin reductase activity.
Ding Z, Song W, Zhu W, Xie H, Zhu Z, Tang W
Frontiers in pediatrics 2023;11:1065521
Frontiers in pediatrics 2023;11:1065521
The effect of hormones insulin and glucagon on ubiquitin modifications elucidated by proteomics in liver cells.
Vemana HP, Dukhande VV
Life sciences 2023 Sep 15;329:121935
Life sciences 2023 Sep 15;329:121935
HMGB1/GPC3 dual targeting vaccine induces dendritic cells-mediated CD8(+)T cell immune response and elicits potential therapeutic effect in hepatocellular carcinoma.
Shi X, Ding J, Zheng Y, Wang J, Sobhani N, Neeli P, Wang G, Zheng J, Chai D
iScience 2023 Mar 17;26(3):106143
iScience 2023 Mar 17;26(3):106143
Enhanced glypican-3-targeted identification of hepatocellular carcinoma with liver fibrosis by pre-degrading excess fibrotic collagen.
Zhuo J, Wang Y, Hui H, Li C, Yang J, Zhang P, Fang C, Tian J
Acta biomaterialia 2023 Mar 1;158:435-448
Acta biomaterialia 2023 Mar 1;158:435-448
Therapeutic Adenovirus Vaccine Combined Immunization with IL-12 Induces Potent CD8(+) T Cell Anti-Tumor Immunity in Hepatocellular Carcinoma.
Zheng Y, Lu Z, Ding J, Jiang N, Wang J, Yang J, Song J, Chen H, Fang L, Li H, Tian H, Wang G, Zheng J, Chai D
Cancers 2022 Sep 17;14(18)
Cancers 2022 Sep 17;14(18)
A Case of Early-Stage Gallbladder Cancer, Positive for ALDH1A1, Which Arose from Adenomyomatosis of the Gallbladder.
Iwasa Y, Iwata K, Okuno M, Sugiyama A, Nishigaki Y, Ohashi Y, Tanaka T, Iwashita T, Shimizu M, Tomita E
Diagnostics (Basel, Switzerland) 2022 Nov 7;12(11)
Diagnostics (Basel, Switzerland) 2022 Nov 7;12(11)
TCF11 Has a Potent Tumor-Repressing Effect Than Its Prototypic Nrf1α by Definition of Both Similar Yet Different Regulatory Profiles, With a Striking Disparity From Nrf2.
Wang M, Ren Y, Hu S, Liu K, Qiu L, Zhang Y
Frontiers in oncology 2021;11:707032
Frontiers in oncology 2021;11:707032
The Mutational Features of Aristolochic Acid-Induced Mouse and Human Liver Cancers.
Lu ZN, Luo Q, Zhao LN, Shi Y, Wang N, Wang L, Han ZG
Hepatology (Baltimore, Md.) 2020 Mar;71(3):929-942
Hepatology (Baltimore, Md.) 2020 Mar;71(3):929-942
hPCL3s Promotes Hepatocellular Carcinoma Metastasis by Activating β-Catenin Signaling.
Cai Z, Qian ZY, Jiang H, Ma N, Li Z, Liu LY, Ren XX, Shang YR, Wang JJ, Li JJ, Liu DP, Zhang XP, Feng D, Ni QZ, Feng YY, Li N, Zhou XY, Wang X, Bao Y, Zhang XL, Deng YZ, Xie D
Cancer research 2018 May 15;78(10):2536-2549
Cancer research 2018 May 15;78(10):2536-2549
Butaselen prevents hepatocarcinogenesis and progression through inhibiting thioredoxin reductase activity.
Zheng X, Ma W, Sun R, Yin H, Lin F, Liu Y, Xu W, Zeng H
Redox biology 2018 Apr;14:237-249
Redox biology 2018 Apr;14:237-249
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The Glypican 3 antibody from Proteintech is a rabbit polyclonal antibody to a fusion protein of human Glypican 3. This antibody recognizes human antigen. The Glypican 3 antibody has been validated for the following applications: ELISA, IHC, WB analysis.
